Free fatty acid receptor 1 (FFA1; previously designated GPR40) is a potential therapeutic target for the treatment of diabetes and related metabolic disorders. Agonist-independent or constitutive activity is a feature associated with essentially all G protein-coupled receptors but the extent of this varies substantially between family members. In many situations, detection of such activity can be both assay- and context-dependent and may reflect the presence in the assay of an endogenous agonist. In studies on FFA1, experiments employing cell membrane preparations and the binding of [(35)S]guanosine 5'-O-[γ-thio]triphosphate to G proteins produce data consistent with a high-level constitutive activity of this receptor. Herein, we detail the...
Free fatty acid receptor 2 (FFA2, GPR43) is a G protein-coupled 7-transmembrane receptor for short c...
A set of 1,3,4-thiadiazole-2-carboxamides bearing a substituted biphenyl in the amide portion was sy...
Free fatty acids (FFA) have generally been proposed to regulate pancreatic insulin release by an int...
In recent years, two G protein coupled receptors have been de-orphanised which respond to long chain...
The free fatty acid receptors (FFA) 1 (previously designated GPR40) and FFA4 (previously GPR120) are...
In cells lacking expression of Ca2-mobilizing G proteins, co-expression of human GPR40 and Gq allowe...
FFA2 (GPR43) has been identified as a receptor for short-chain fatty acids (SCFAs) that include acet...
Identification of G protein-coupled receptors that are activated by free fatty acids has led to cons...
Fatty acids, which are essential nutritional components, are also involved in cardiovascular and met...
ABSTRACT: Free fatty acid receptor 1 (FFA1 or GPR40) enhances glucose-stimulated insulin secretion f...
Free fatty acid receptors 2 and 3 (FFA2 and FFA3) are G protein-coupled receptors for short chain fr...
FFA1 (GPR40) is a new target for treatment of type 2 diabetes. We recently identified the potent FFA...
The endogenous ligands for Free Fatty Acid receptor 1 (FFA1) are medium- and longer-chain free fatty...
The free fatty acid receptor 1 (FFA1/GPR40) is a potential target for treatment of type 2 diabetes. ...
FFA1 (GPR40) is a new target for treatment of type 2 diabetes. We recently identified the potent FFA...
Free fatty acid receptor 2 (FFA2, GPR43) is a G protein-coupled 7-transmembrane receptor for short c...
A set of 1,3,4-thiadiazole-2-carboxamides bearing a substituted biphenyl in the amide portion was sy...
Free fatty acids (FFA) have generally been proposed to regulate pancreatic insulin release by an int...
In recent years, two G protein coupled receptors have been de-orphanised which respond to long chain...
The free fatty acid receptors (FFA) 1 (previously designated GPR40) and FFA4 (previously GPR120) are...
In cells lacking expression of Ca2-mobilizing G proteins, co-expression of human GPR40 and Gq allowe...
FFA2 (GPR43) has been identified as a receptor for short-chain fatty acids (SCFAs) that include acet...
Identification of G protein-coupled receptors that are activated by free fatty acids has led to cons...
Fatty acids, which are essential nutritional components, are also involved in cardiovascular and met...
ABSTRACT: Free fatty acid receptor 1 (FFA1 or GPR40) enhances glucose-stimulated insulin secretion f...
Free fatty acid receptors 2 and 3 (FFA2 and FFA3) are G protein-coupled receptors for short chain fr...
FFA1 (GPR40) is a new target for treatment of type 2 diabetes. We recently identified the potent FFA...
The endogenous ligands for Free Fatty Acid receptor 1 (FFA1) are medium- and longer-chain free fatty...
The free fatty acid receptor 1 (FFA1/GPR40) is a potential target for treatment of type 2 diabetes. ...
FFA1 (GPR40) is a new target for treatment of type 2 diabetes. We recently identified the potent FFA...
Free fatty acid receptor 2 (FFA2, GPR43) is a G protein-coupled 7-transmembrane receptor for short c...
A set of 1,3,4-thiadiazole-2-carboxamides bearing a substituted biphenyl in the amide portion was sy...
Free fatty acids (FFA) have generally been proposed to regulate pancreatic insulin release by an int...